Intravenous Iron Replacement Therapy Improves Cardiovascular Outcomes in Hemodialysis Patients

Background/Aim: More than half of deaths among hemodialysis patients are due to cardiovascular disease. This study examined whether intravenous administration of ferric carboxymaltose (FCM) has an impact on cardiovascular events in iron-deficient hemodialysis patients. Patients and Methods: We perfo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:In Vivo
Main Authors: RIGHINI, MATTEO, DALMASTRI, VITTORIO, CAPELLI, IRENE, ORSI, CLAUDIO, DONATI, GABRIELE, PALLOTTI, MARIA GIOVANNA, PEDONE, CHIARA, CASELLA, GIANNI, CHIECO, PASQUALE, MANNA, GAETANO LA
Formato: Artigo
Idioma:Inglês
Publicado em: International Institute of Anticancer Research 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8193293/
https://ncbi.nlm.nih.gov/pubmed/33910844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12419
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados